miR-4417 suppresses keloid fibrosis growth by inhibiting CyclinD1.

In conclusion, miR-4417 and CyclinD1 may be potential therapeutic targets for the treatment of keloid.
PMID: 32345773 [PubMed - in process]

Source: Journal of Biosciences - May 2, 2020 Category: Biomedical Science Authors: Liu P, Hu Y, Xia L, DU M, Hu Z Tags: J Biosci Source Type: research